OPTEL has been chosen to participate in the U.S. Food and Drug Administration’s Drug Supply Chain Security Act (DSCSA) Pilot Project Program to help identify and trace prescription drugs as they are distributed within the United States.
Nelipak and OPTEL have entered into an agreement of intent to explore commercial opportunities for a new seal inspection technology for medical devices. The novel concept for vacuum-formed trays will be demonstrated at MedtecLIVE 2019.
On the heels of the Implant Files report, OPTEL posted an article detailing how supply chain traceability could improve the safety of medical devices. Plastics Today interviewed Simon Bastarache, Industry Leader, Medical Devices.
Pharmacies that have yet to comply with the European Union’s Falsified Medicines Directive (EU FMD) can now do so in just a few clicks, thanks to a new transactional website for OPTEL Certa™ Software verification and decommissioning solution.
Real Leaders, Big Path Capital, and B Lab have teamed up to assess and rank the “100 Top Impact Companies” of 2019 and are proud to announce that OPTEL ranked 6 out of 99 inaugurals winners!
OPTEL has made CIO Review’s 2018 list of Top 10 Most Promising Food and Beverages Solutions Providers, compiled by a panel of prominent CEOs, CIOs, VCs and analysts, along with CIO Review’s editorial board, to “help your company analyze the best solution provider that will boost your business.”
OPTEL GROUP’s commitment to creating a better world through
responsible capitalism has earned a nod from the 2018 Limerick Chamber Regional Business Awards,
which honours businesses that operate with success and distinction in the region of Limerick, Ireland.
OPTEL was awarded the prize for Supply Chain Achievement on the strength of a submission outlining the development of its Intelligent Supply Chain™, which combines the company’s recognized traceability expertise and the power of cutting-edge technologies such as cloud-based computing, artificial intelligence and the Internet of Things.
OPTEL GROUP, the world’s leading supplier of traceability solutions, is leveraging its 30 years of experience serving the pharmaceutical industry to help a major French hospital comply with the European Union’s Falsified Medicines Directive (EU FMD) for hospital pharmacies.
OPTEL, the world’s leading provider of traceability solutions, is helping five Irish pharmacies prepare for compliance with the European Union’s Falsified Medicines Directive (EU FMD) by providing the software and hardware required to connect to the Irish Medicines Verification Organisation (IMVO).
OPTEL GROUP, OPTEL is proud to announce that it is now officially connected to the Irish Medicines Verification Organization (IMVO), part of the European Medicines Verification System (EMVS). OPTEL has obtained the Single Pack transaction self-certification, demonstrating the complete connectivity to the IMVO and approval of the single pack functionality following multiple test cases.
OPTEL GROUP, a leading global provider of traceability systems for diverse industries, announced today that GeoTraceability,
OPTEL GROUP is proud to announce that it has been attributed “Silver” status by business sustainability experts, EcoVadis, further reinforcing OPTEL’s position as a supplier of choice, who is mindful of its social and environmental impact.
De La Rue and OPTEL today announced a strategic partnership to address the growing threat of global counterfeiting.
OPTEL Group shows once more its commitment toward sustainable mobility by acquiring the VÉLOSYMPATHIQUE movement (cycling-friendly) bronze certification from Vélo Québec.
The technology Headlines has announced the release of their latest edition "10 fastest Growing Manufacturing Solutions Provides to Watch in 2018", with OPTEL Group as No.1!
OPTEL GROUP is pleased to announce that the AI-Powered Supply Chain Consortium it is part of was named one of the five official winners of the Innovation Supercluster Initiative led by the Government of Canada.
OPTEL GROUP, a leading global provider of traceability systems for diverse industries ─ namely, pharmaceuticals and medical devices ─ is pleased to announce that it is expanding its traceability offering even further through the acquisition of GeoTraceability.
OPTEL GROUP announced today that it has signed an agreement to pilot OPTEL’s Certa decommissioning solution at Oxford University Hospitals
OPTEL GROUP announced today that it is now the first company in Quebec City to officially become a Certified B Corporation
OPTEL GROUP announced today that it is expanding its traceability offering through the acquisition of Verify Brand.
Louis Roy, President and Founder of Optel Groupis named Canada's EY Entrepreneur Of The Year™ 2017 National award winner.
OPTEL GROUP announced today that Desjardins Group is providing the company with CAD $68 million in loans in order to support its growth and expansion plans.
President and Founder of OPTEL Group is not only named the EY Entrepreneur of the Year within the Business-to-Business Products and Services category, but also for the entire province of Quebec!
This high-definition, high-speed digital inkjet printing system works as an all in-one, drop on demand and inspection solution, rendering it highly versatile and able to work with large web printing and high volumes.
The Minister of Innovation, Science and Economic Development of Canada, the Honourable Navdeep Bains, announced today that nine applicants have been shortlisted in the second phase of the Innovation Superclusters Initiative.
OPTEL GROUP continues to expand its international customer base through a higher production capacity and fast turnaround time.
OPTEL GROUP announced today that it will be exhibiting an entire serialized line at this year’s PACK EXPO Las Vegas, from September 25 to 27.
The FDA announced that it is now allowing additional time for pharmaceutical manufacturers to comply with product identifier requirements
OPTEL embarks on a project that is as original as it is beneficial: urban beekeeping.
Mikart Inc., a contract development and manufacturing organization, is fully compliant with 2017 through 2023 Drug Supply Chain Security Act (DSCSA) mandates for serialization and aggregation.
Following Successful Growth in Canada, Ireland and India, OPTEL Now Opens Site in Brazil
The world has lost a thought leader, a mentor, a friend, a husband and father…and an amazing mind. GS1 has lost one of our family.
Optel Vision Launched Fast Series – preconfigured units enabling pharmaceutical packaging lines to meet compliance fast.
OPTEL GROUP announced today that MarketsandMarkets, determined that Optel Vision is the leading player in its field with an overall market share of 25.7%.
OPTEL GROUP announced today the launch of its new Fast Series, a line of preconfigured Track & Trace products that are specially designed to help pharmaceutical manufacturers meet compliance requirements, fast.
Member of Optel Group, Optel Vision, a leading provider of inspection and serialization systems for the global pharmaceutical industry, announced today that it officially opened its new site in Goa, India.
Optel Vision Launches Open SiteMaster 2.0, a Powerful Plant-Level Server Software Combining Serialization Expertise with Unparalleled Agility
All employees and managers of Optel Group and its business units are committed to respecting this environmental policy.